Literature DB >> 603738

Simple lignocaine regimen for transit to hospital after myocardial infarction.

J M Barber, D M Boyle, Z Hussain, D G McDevitt.   

Abstract

A simple combined intravenous/intramuscular regimen is described for lignocaine administration in the early vulnerable stage of myocardial infarction. Plasma levels in the therapeutic range are attained. This allows adequate drug protection during transport to hospital when an intravenous regimen may be impractical or impossible.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 603738      PMCID： PMC483422          DOI： 10.1136/hrt.39.12.1361

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


  7 in total

Review 1.  Drug interactions in cardiovascular therapy.

Authors:  J Koch-Weser; J Koch-Weser
Journal:  Am Heart J       Date:  1975-07       Impact factor: 4.749

2.  Logical approach to lignocaine therapy.

Authors:  C Aps; J A Bell; B S Jenkins; P A Poole-Wilson; F Reynolds
Journal:  Br Med J       Date:  1976-01-03

Review 3.  The clinical pharmacology of lidocaine as an antiarrhythymic drug.

Authors:  K A Collinsworth; S M Kalman; D C Harrison
Journal:  Circulation       Date:  1974-12       Impact factor: 29.690

4.  Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction. A double-blind study.

Authors:  P A Valentine; J L Frew; M L Mashford; J G Sloman
Journal:  N Engl J Med       Date:  1974-12-19       Impact factor: 91.245

5.  A mobile intensive-care unit in the management of myocardial infarction.

Authors:  J F Pantridge; J S Geddes
Journal:  Lancet       Date:  1967-08-05       Impact factor: 79.321

6.  Mobile coronary care.

Authors:  M J Walsh; G Shivalingappa; K Scaria; C Morrison; B Kumar; C Farnan; N C Chaturvedi; D M Boyle; J M Barber
Journal:  Br Heart J       Date:  1972-07

7.  Pharmacokinetics of lidocaine in man.

Authors:  R N Boyes; D B Scott; P J Jebson; M J Godman; D G Julian
Journal:  Clin Pharmacol Ther       Date:  1971 Jan-Feb       Impact factor: 6.875
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.